Alan Dal Pra

Citado por

	Total	Desde 2019
Citas	3777	2614
Índice h	26	21
Índice i10	56	45

560

280

140

420

201220132014201520162017201820192020202120222023202417 43 66 135 206 282 383 433 428 555 496 477 220

Acceso público

Ver todo

24 artículos

5 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Matthew AbramowitzUniversity of MiamiDirección de correo verificada de med.miami.edu
Radka StoyanovaProfessorDirección de correo verificada de med.miami.edu
Olgun ElicinDepartment of Radiation Oncology, Inselspital, Bern University Hospital, and University of BernDirección de correo verificada de insel.ch
Alexandros PapachristofilouUniversity Hospital BaselDirección de correo verificada de usb.ch
Alejandro BerlinClinician-Scientist, Radiation Oncology, Princess Margaret Cancer Centre, University of TorontoDirección de correo verificada de rmp.uhn.ca
Van der Kwast TUniversity Health NetworkDirección de correo verificada de uhn.ca
Paul C. BoutrosUniversity of California, Los AngelesDirección de correo verificada de mednet.ucla.edu
Bradly WoutersPrincess Margaret Cancer Centre, University Health Network, University of TorontoDirección de correo verificada de uhnresearch.ca
Stéphane SupiotUniversity of NantesDirección de correo verificada de ico.unicancer.fr
Stefanie HayozSwiss Group for Clinical Cancer Research (SAKK)Dirección de correo verificada de sakk.ch
A GOMEZ- ITURRIAGABioizkaia Health Research Institute, Basque Country University UPV/EHUDirección de correo verificada de osakidetza.eus
Marianne KoritzinskyUniversity of TorontoDirección de correo verificada de uhnresearch.ca
Trevor McKeeAdjunct Lecturer, Department of Laboratory Medicine and Pathobiology, University of TorontoDirección de correo verificada de utoronto.ca
Shawn StapletonMD AndersonDirección de correo verificada de mdanderson.org
Neil FleshnerProfessor, university of TORONTODirección de correo verificada de utoronto.ca
Wan L. LamBC Cancer Research Centre; University of British ColumbiaDirección de correo verificada de bccrc.ca
Jeremy SquireDepartmento de Genética, Faculdade de Medicina de Ribeirão Preto, University of Sao PauloDirección de correo verificada de fmrp.usp.br
Filippo AlongiDirettore Radioterapia Oncologica, Ospedale Sacro Cuore, Negrar (Verona)Dirección de correo verificada de sacrocuore.it
Nikola CihoricMDDirección de correo verificada de insel.ch
Alexandros TsikkinisGerman Oncology CenterDirección de correo verificada de goc.com.cy

Seguir

Alan Dal Pra

University of Miami Miller School of Medicine

Dirección de correo verificada de med.miami.edu

Radiation Oncology Genitourinary Oncology


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017	594	2017
Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015	523	2015
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The lancet oncology 15 (13), 1521-1532, 2014	376	2014
Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response VE Zannella, A Dal Pra, H Muaddi, TD McKee, S Stapleton, J Sykes, ... Clinical cancer research 19 (24), 6741-6750, 2013	320	2013
A prostate cancer “nimbosus”: genomic instability and SChLAP1 dysregulation underpin aggression of intraductal and cribriform subpathologies MLK Chua, W Lo, M Pintilie, J Murgic, E Lalonde, V Bhandari, ... European urology 72 (5), 665-674, 2017	172	2017
A systematic review of the evidence for the decipher genomic classifier in prostate cancer NK Jairath, A Dal Pra, R Vince Jr, RT Dess, WC Jackson, JJ Tosoian, ... European urology 79 (3), 374-383, 2021	119	2021
IDH mutation status in prostate cancer AF Ghiam, RA Cairns, J Thoms, A Dal Pra, O Ahmed, A Meng, TW Mak, ... Oncogene 31 (33), 3826-3826, 2012	94	2012
Plasma osteopontin as a biomarker of prostate cancer aggression: relationship to risk category and treatment response JW Thoms, A Dal Pra, PH Anborgh, E Christensen, N Fleshner, C Menard, ... British journal of cancer 107 (5), 840-846, 2012	73	2012
Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy B Malla, DM Aebersold, A Dal Pra Journal of translational medicine 16, 1-13, 2018	71	2018
Exosomes and exosomal microRNAs in prostate cancer radiation therapy B Malla, K Zaugg, E Vassella, DM Aebersold, A Dal Pra International Journal of Radiation Oncology* Biology* Physics 98 (5), 982-995, 2017	67	2017
Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation B Bojaxhiu, AJ Templeton, O Elicin, M Shelan, K Zaugg, M Walser, ... Radiation oncology 13, 1-9, 2018	61	2018
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy RG Bristow, A Berlin, A Dal Pra The British journal of radiology 87 (1035), 20130753, 2014	54	2014
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist J Cacicedo, A Navarro, O Del Hoyo, A Gomez-Iturriaga, F Alongi, ... The British journal of radiology 89 (1067), 20160217, 2016	53	2016
Objective consensus from decision trees PM Putora, CM Panje, A Papachristofilou, AD Pra, T Hundsberger, ... Radiation oncology 9, 1-8, 2014	52	2014
Combining radiation therapy and androgen deprivation for localized prostate cancer—a critical review A Dal Pra, FL Cury, L Souhami Current Oncology 17 (5), 28-38, 2010	51	2010
TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ... Clinical cancer research 19 (18), 5202-5209, 2013	50	2013
Synergistic action of image-guided radiotherapy and androgen deprivation therapy JA Locke, AD Pra, S Supiot, P Warde, RG Bristow Nature Reviews Urology 12 (4), 193-204, 2015	49	2015
Segmentation of prostate and prostate zones using deep learning: A multi-MRI vendor analysis O Zavala-Romero, AL Breto, IR Xu, YCC Chang, N Gautney, A Dal Pra, ... Strahlentherapie und Onkologie 196, 932-942, 2020	48	2020
Intratumoral hypoxia as the genesis of genetic instability and clinical prognosis in prostate cancer D Taiakina, AD Pra, RG Bristow Tumor microenvironment and cellular stress: signaling, metabolism, imaging …, 2014	39	2014
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus T Zilli, V Achard, A Dal Pra, N Schmidt-Hegemann, BA Jereczek-Fossa, ... Radiotherapy and Oncology 176, 199-207, 2022	38	2022

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores